{"entity":{"type":"insider","cik":"0001577014","url":"/insider/0001577014","json_url":"/insider/0001577014.json","name":"Rhodes Jason P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":240,"n_filings":34,"first":"2014-01-06","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Rhodes Jason P","source":"filing","n_filings":34,"first_seen":"2014-01-06","last_seen":"2026-08-17"}],"transactions":[{"id":9292390,"accession":"0001577014-26-000016","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001577014-26-000016","line_url":"/filing/0001577014-26-000016","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2160516.0,"shares_display":"2,160,516","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":54012900.0,"total_display":"54,012,900.00","total_whole":"54,012,900","shares_owned_after":428946.0,"shares_owned_after_display":"428,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-17","scope":"insider","n_lines":3},{"id":9292391,"accession":"0001577014-26-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001577014-26-000016","line_url":"/filing/0001577014-26-000016","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":426412.0,"shares_display":"426,412","price_per_share":26.2,"price_display":"26.20","price_state":"stated","total_value":11171994.4,"total_display":"11,171,994.40","total_whole":"11,171,994","shares_owned_after":1045735.0,"shares_owned_after_display":"1,045,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-17","scope":"insider","n_lines":3},{"id":5906799,"accession":"0001577014-26-000014","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001577014-26-000014","line_url":"/filing/0001577014-26-000014","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":297211.0,"shares_display":"297,211","price_per_share":23.26233574800394,"price_display":"23.26","price_state":"stated","total_value":6913822.07,"total_display":"6,913,822.07","total_whole":"6,913,822","shares_owned_after":4099069.0,"shares_owned_after_display":"4,099,069","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-08","scope":"insider","n_lines":7},{"id":5906787,"accession":"0001577014-26-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001577014-26-000014","line_url":"/filing/0001577014-26-000014","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":480240.0,"shares_display":"480,240","price_per_share":22.79,"price_display":"22.79","price_state":"stated","total_value":10944669.6,"total_display":"10,944,669.60","total_whole":"10,944,670","shares_owned_after":4223448.0,"shares_owned_after_display":"4,223,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider","n_lines":3},{"id":5777938,"accession":"0001577014-26-000012","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001577014-26-000012","line_url":"/filing/0001577014-26-000012","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195427.0,"shares_display":"195,427","price_per_share":21.14,"price_display":"21.14","price_state":"stated","total_value":4131326.78,"total_display":"4,131,326.78","total_whole":"4,131,327","shares_owned_after":4476487.0,"shares_owned_after_display":"4,476,487","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-06-30","scope":"insider","n_lines":3},{"id":5777935,"accession":"0001577014-26-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001577014-26-000012","line_url":"/filing/0001577014-26-000012","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":309268.0,"shares_display":"309,268","price_per_share":21.28,"price_display":"21.28","price_state":"stated","total_value":6581223.04,"total_display":"6,581,223.04","total_whole":"6,581,223","shares_owned_after":4579456.0,"shares_owned_after_display":"4,579,456","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider","n_lines":3},{"id":5741107,"accession":"0001577014-26-000010","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001577014-26-000010","line_url":"/filing/0001577014-26-000010","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24100.0,"shares_display":"24,100","price_per_share":21.1,"price_display":"21.10","price_state":"stated","total_value":508510.0,"total_display":"508,510.00","total_whole":"508,510","shares_owned_after":4742410.0,"shares_owned_after_display":"4,742,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-25","filed_date":"2026-06-26","scope":"insider","n_lines":3},{"id":5741100,"accession":"0001577014-26-000010","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001577014-26-000010","line_url":"/filing/0001577014-26-000010","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95900.0,"shares_display":"95,900","price_per_share":21.02,"price_display":"21.02","price_state":"stated","total_value":2015818.0,"total_display":"2,015,818.00","total_whole":"2,015,818","shares_owned_after":4755109.0,"shares_owned_after_display":"4,755,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-26","scope":"insider","n_lines":3},{"id":5741094,"accession":"0001577014-26-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001577014-26-000010","line_url":"/filing/0001577014-26-000010","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147760.0,"shares_display":"147,760","price_per_share":21.13,"price_display":"21.13","price_state":"stated","total_value":3122168.8,"total_display":"3,122,168.80","total_whole":"3,122,169","shares_owned_after":4805639.0,"shares_owned_after_display":"4,805,639","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-26","scope":"insider","n_lines":3},{"id":5766123,"accession":"0001577014-26-000008","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001577014-26-000008","line_url":"/filing/0001577014-26-000008","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83219.0,"shares_display":"83,219","price_per_share":18.18,"price_display":"18.18","price_state":"stated","total_value":1512921.42,"total_display":"1,512,921.42","total_whole":"1,512,921","shares_owned_after":4883494.0,"shares_owned_after_display":"4,883,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-06","filed_date":"2026-05-06","scope":"insider","n_lines":4},{"id":5766117,"accession":"0001577014-26-000008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001577014-26-000008","line_url":"/filing/0001577014-26-000008","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11600.0,"shares_display":"11,600","price_per_share":18.03,"price_display":"18.03","price_state":"stated","total_value":209148.0,"total_display":"209,148.00","total_whole":"209,148","shares_owned_after":4927115.0,"shares_owned_after_display":"4,927,115","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-06","scope":"insider","n_lines":4},{"id":5766111,"accession":"0001577014-26-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001577014-26-000008","line_url":"/filing/0001577014-26-000008","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11904.0,"shares_display":"11,904","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":214272.0,"total_display":"214,272.00","total_whole":"214,272","shares_owned_after":4933196.0,"shares_owned_after_display":"4,933,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-06","scope":"insider","n_lines":4},{"id":5994997,"accession":"0001577014-26-000006","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001577014-26-000006","line_url":"/filing/0001577014-26-000006#line-8","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119115.0,"shares_display":"119,115","price_per_share":18.38,"price_display":"18.38","price_state":"stated","total_value":2189333.7,"total_display":"2,189,333.70","total_whole":"2,189,334","shares_owned_after":4939489.0,"shares_owned_after_display":"4,939,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":5994994,"accession":"0001577014-26-000006","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001577014-26-000006","line_url":"/filing/0001577014-26-000006#line-7","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59870.0,"shares_display":"59,870","price_per_share":18.38,"price_display":"18.38","price_state":"stated","total_value":1100410.6,"total_display":"1,100,410.60","total_whole":"1,100,411","shares_owned_after":1577432.0,"shares_owned_after_display":"1,577,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":5994992,"accession":"0001577014-26-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001577014-26-000006","line_url":"/filing/0001577014-26-000006#line-6","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47082.0,"shares_display":"47,082","price_per_share":18.38,"price_display":"18.38","price_state":"stated","total_value":865367.16,"total_display":"865,367.16","total_whole":"865,367","shares_owned_after":1158944.0,"shares_owned_after_display":"1,158,944","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":5994990,"accession":"0001577014-26-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001577014-26-000006","line_url":"/filing/0001577014-26-000006#line-5","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1170.0,"shares_display":"1,170","price_per_share":18.38,"price_display":"18.38","price_state":"stated","total_value":21504.6,"total_display":"21,504.60","total_whole":"21,505","shares_owned_after":8512.0,"shares_owned_after_display":"8,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":5994987,"accession":"0001577014-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001577014-26-000006","line_url":"/filing/0001577014-26-000006#line-4","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52.0,"shares_display":"52","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":988.0,"total_display":"988.00","total_whole":"988","shares_owned_after":4939437.0,"shares_owned_after_display":"4,939,437","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":5994985,"accession":"0001577014-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001577014-26-000006","line_url":"/filing/0001577014-26-000006#line-3","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26.0,"shares_display":"26","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":494.0,"total_display":"494.00","total_whole":"494","shares_owned_after":1577406.0,"shares_owned_after_display":"1,577,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":5994982,"accession":"0001577014-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001577014-26-000006","line_url":"/filing/0001577014-26-000006#line-2","is_derivative":false,"issuer_cik":"0001577014","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001577014","owner_cik":"0001577014","owner_name":"Rhodes Jason P","owner_display_name":"Rhodes Jason P","owner_url":"/insider/0001577014","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21.0,"shares_display":"21","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":399.0,"total_display":"399.00","total_whole":"399","shares_owned_after":1158923.0,"shares_owned_after_display":"1,158,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"}],"collapsed":true,"next_cursor":"2026-04-28|5994982","ledger_fault":false,"count":{"value":240,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":238,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":240},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Director","n_filings":14,"first_seen":"2022-12-14","last_seen":"2026-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Director","n_filings":6,"first_seen":"2021-04-09","last_seen":"2021-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Director","n_filings":6,"first_seen":"2019-11-20","last_seen":"2021-01-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer (President, CFO and Treasurer)","n_filings":8,"first_seen":"2014-01-06","last_seen":"2014-09-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001577014","retrieved_at":"2026-08-24T00:33:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}